Search
Displaying 611–620 of 865 results for “vision connection”
-
Retinal Research Community Loses Beloved Pioneer Sam Jacobson
Beacon StoriesHis many contributions included pivotal work that led to LUXTURNA
-
Hello my name is Josephine Ortega , I am a college student continuing her passion of art despite me being visually impaired. I was diagnosed with Stargardt disease when I was a child. A rare genetic eye disease that loses the central vision overtime as a child to adulthood.
-
Opus Genetics to Launch Gene Therapy Clinical Trial for LCA5 Patients
Research NewsThe LCA5 gene therapy will be the first emerging Opus treatment to move into a human study
-
Recap of Retinal Disease News from the 2022 Meeting of the American Academy of Ophthalmology
Research NewsReports on emerging therapies for dry age-related macular degeneration (geographic atrophy), Stargardt disease, and X-linked retinitis pigmentosa are included
-
PRPH2 and Associated Retinal Diseases Workshop
Save the Date! The PRPH2 and AAssociated Retinal Diseases Workshop will be on March 29-31, 2023, at the Hilton La Jolla Torrey Pines in San Diego, CA.
-
To help spread awareness during October Blindness Awareness Month, we’re inviting you to share your vision-loss journey through written word, audio or video as a part of our October “Share Your Vision” campaign. Visit www.FightingBlindness.org/ShareYourVision to learn more.
-
To help spread awareness during October Blindness Awareness Month, we’re inviting you to share your vision-loss journey through written word, audio or video as a part of our October “Share Your Vision” campaign. Visit www.FightingBlindness.org/ShareYourVision to learn more.
-
Colin was born in the small Western New York Community of Jamestown. His emersion into the arts started naturally, his mother was a designer and his father an art and antiques collector.
-
RD Fund Participates in a €75 Million Series B for SparingVision
In the PressProceeds to fund first, in-human trials of breakthrough gene-agnostic therapy products and advance CRISPR-based genome editing portfolio.
-
Endogena Launches Clinical Trial of Therapy to Activate Stem Cells in RP Patients’ Retinas
Research NewsThe emerging treatment is gene-agnostic.
.png)
.png)
